Jeff Abraham, CEO for Absorption Pharmaceuticals, was featured on KFI AM 640 on Wednesday, August 6, 2014, where he discussed Promescent, the first FDA-approved treatment for premature ejaculation (PE ...
Are you a print subscriber? Activate your account. By Will Johnson - 5 hours 56 min ago By Ewan Larkin - 6 hours 26 min ago 6 hours 26 min ago By Garett Sloane - 6 hours 26 min ago By Adrianne ...
Promescent CEO Jeff Abraham details the company's lawsuit against consumer giant Reckitt Benckiser for $150 million, alleging fraud and theft of trade secrets. Got a confidential news tip? We want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results